9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery

Top West Virginia Mesothelioma Lawyer | Law Firm | Attorney | GPW > S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery

S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery

Estimated reading time: < 1 min

Condition: Malignant Mesothelioma

Estimated Enrollment: 61

Gender: All

Min Age: 18 Years

Age Group: Adult, Older Adult

Current Status: Completed

Study Results: Has Results

Outcome Measures: Progression-Free Survival,  Response,  Overall Survival, Frequency and Severity of Toxicities

Interventions: everolimus,

Phase:

Study Type: Interventional

Study Design: Intervention Model: Single Group Assignment, Masking: None (Open Label), Primary Purpose: Treatment,

Primary Completion Date: April 2014

Completion Date: April 2014

Last  Posted Date: March 1, 2017

Location: Arizona Cancer Center at University of Arizona Health Sciences Center, Tucson, Arizona, United States

Website Link: https://ClinicalTrials.gov/show/NCT00770120

Was this article helpful?
Dislike 0